Immunology/haematology Flashcards
Cyclophosphamide mechanism of action?
Alkylation (cross linking) of DNA in S phase.
T and B cell lymphopenia, suppresses T cell activity and AB production
Acrolein bladder tox.
Azathioprine mechanism of action?
Purine analogue, metabolised to ribonucleotide monophosphates (6mercaptopurine) and inhibits enzymes required for purine biosynthesis. DNA incorporation causes RNA miscoding.
Humoral > cell mediated immunity. Decreases lymphocyte activation and proliferation (lack of purine salvage pathway). Decreases macrophage function.
Active form metabolised by thiopurine methyltransferase and xanthine oxidase.
Relevant breeds and medications for azathioprine use?
Giant schnauzer/cat - low TPMT activity. Malamute - high TPMT activity. Allopurinol inhibits XO.
Methotrexate mechanism of action?
Inhibits (competitive) folic acid reductase - no purine/pyrimidine synthesis. Mostly S phase.
Glucocorticoid mechanism of action?
Cytosolic glucocorticoid receptors (vary with tissue), glucocorticoid response elements, gene transcription.
Stabilise endothelial membranes, decrease chemotactic factors/cytokines/adhesion molecules. Inhibit arachidonic acid release.
Dose dependent, cellular/humoral.
Decrease pro inflamm cytokines, complement function, T cell proliferation/AB production, macrophage Fc receptors
Increase anti inflamm cytokines
Redistribute mono/lymphocytes, mainly T, to bone marrow and lymphatics.
How much mineralocorticoid activity do the various steroids have in comparison to cortisol?
Prednisolone 0.3 - 0.8
Dex 0
Hydrocortisone 0.8 - 1
Cyclosporin mechanism of action?
Cyclosporin/cyclophilin compleex binds and inhibits calcineurin. Impedes calcium dependent signal transduction/dephosphorylation, impedes activation of nuclear factors of activated T cells. No nuclear transcription of IL2 so decreased T cell activation/proliferation.
Cytotoxic T cell activity decreased.
Stimulates TGFbeta production which inhibits IL2-stimulated T cell proliferation and generation of antigen-spec cytotoxic T cells.
NB need ultramicronised microemulsion (better absorption)
Cytochrome p450 metab, biliary excretion. Peak conc 2h
Pharmacodynamic evaluation measures IL2 and IFN gamma.
Hepato-nephrotixicity v uncommon
Side effects of ciclosporin?
Secondary inf gingival hyperplasia hirsutism
Tacrolimus mechanisms of action?
Similar to cyclosporin - FKbinding protein complex, decrease T cell activation.
Does B and T cells and ABs. More potent than cyclosporin.
Mechanisms of action of sirolimus/rapamycin?
mTOR inhibition
(T cell G1 - S, cyclosporin G0 - G1)
T and B cells
Mechanism of action mycofenolate?
Hydrolysed to mycophenolic acid by the liver (active form).
Inhibits inosine monophosphate dehydrogenase in activated lymphocytes (needed for de novo purine biosynthesis). Prevents guanosine and deoxyguanosine biosynthesis.
Inh B and T cell proliferation. Decrease AB production. Apoptosis activated T cells. Humoral and cell med immunity, decrease adhesion and lymphocyte/mono recruitment
Hepatic glucuronidation inactivates to mycophenolic acid glucuronide which is excreted in bile (intestine flora deglucuronidate so get second peak). 90 % excreted in urine as MPAG.
Leflunomide mechanism of action?
Inhibit de novo PYRAMIDINE synthesis. Dihydroorotate dehydrogenase inhibitor.
B and T lymphocyte - decrease proliferation, decrease leucocyte adhesion, decrease IgG synth.
Activates by intestinal mucosa/liver to teriflunomide.
Renal excretion of trimethylfluoroanaline - susceptible tox if renal insufficiency.
Chlorambucil mechanism of action?
Non cell cycle specific alkylating agent. Cross links DNA. Inhibits resting/dividing cells, esp lymphocytes - cell and humeral immunity inhibition.
Inactivated by the liver
How are RBCs destroyed in extravascular/intravascular haemolysis?
Extra - macrophages in spleen
Intra - complement mediated - IgM ABs activate
Antierythrocyte ABs from B cells, but T cell (CD4 driven disease)
What genetic factors are there for development of IMHA?
Breed - cocker spaniel, familial association
Autoreactive T cells in siblings
DLA haplotype?
Most common antigen in IMHA?
Anion exchange molecule/erythrocyte membrane glycoproteins
What seasons is IMHA most common in?
Spring and early summer
Percentage of idiopathic IMHA?
70 - 80 %
What antibodies are most common canine IMHA?
IgG or IgG plus IgM (rare to have only IgM)
Increased pro-inflamm cytokines IMHA?
Monocyte chemoattractant protein 1, GMCSF (assoc with mortality also IL15 and 18)
Why might thromboembolism occur in IMHA?
DIC - evidence present 50 %
What do platelets express more of in IMHA?
P-selectin - activation (driven by cytokines)
Negative prognostic indicators canine IMHA?
Hyperbilirubinemia, thrombocytopenia, leucotyosis with left shift, azotaemia, hypoalbuminaemia, intravascular haemolysis, prolonged hyperlactataemia hepatic insufficiency, macrophage activating cytokines, autoagglutination, increased aPT.
What is NOT associated with IMHA outcome?
Degree of anaemia, magnitude reticulocyte response (1/3 present non-reg), degree of spherocytosis